6.68

11.15% 0.67

After Hours: 6.66 -0.02 -0.30%

Alpha Cognition Inc (ACOG)

Overview News Price History Discussions Forecast

Alpha Cognition Inc stock is traded at $6.68, with a volume of 45,426. It is up +11.15% in the last 24 hours and up +10.96% over the past month. Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Previous Close:

$6.01

Open:

$6.09

24h Volume:

45,426

Relative Volume:

0.96

Market Cap:

$145.45M

Revenue:

$10.83M

Net Income/Loss:

$-25.14M

P/E Ratio:

-4.8674

EPS:

-1.3724

Net Cash Flow:

$-30.41M

1W Performance:

+11.52%

1M Performance:

+10.96%

6M Performance:

+24.86%

1Y Performance:

-26.55%

1-Day Range:

$5.95

$6.70

1-Week Range:

$5.8101

$6.70

52-Week Range:

$4.50

$11.54

Alpha Cognition Inc Stock (ACOG) Company Profile

Name

Alpha Cognition Inc

Sector

Healthcare (1100)

Industry

Biotechnology (615)

Phone

(858) 344-4375

Address

1452 HUGHES RD., STE. 200, GRAPEVINE

Employee

Twitter

Next Earnings Date

2026-05-14

Latest SEC Filings

ACOG's Discussions on Twitter

Compare ACOG vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ACOG Alpha Cognition Inc	6.68	130.43M	10.83M	-25.14M	-30.41M	-1.3724
VRTX Vertex Pharmaceuticals Inc	458.99	114.33B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	607.93	64.47B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	892.26	54.99B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	282.72	38.42B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	157.77	34.03B	742.00K	-1.37B	-1.07B	-7.0731

Alpha Cognition Inc Stock (ACOG) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-17-26	Initiated	Craig Hallum	Buy
Mar-18-25	Initiated	H.C. Wainwright	Buy

Alpha Cognition Inc Stock (ACOG) Latest News

Jun 14, 2026

Alpha Cognition (ACOG) Slips Modestly, Support Level Tested AgainVolume Rate Change - newsline.com

Jun 14, 2026

Jun 13, 2026

ACOG Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Jun 13, 2026

We Think Alpha Cognition (NASDAQ:ACOG) Needs To Drive Business Growth Carefully - Yahoo Finance

Jun 13, 2026

Jun 12, 2026

ACOG Technical Analysis & Stock Price Forecast - Intellectia AI

Jun 12, 2026

Major Investor Quietly Boosts Stake in Alpha Cognition With Fresh Buy-In - TipRanks

Jun 12, 2026

Jun 11, 2026

Alpha Cognition (ACOG) 10K Form and Latest SEC Filings 2026 - MarketBeat

Jun 11, 2026

Jun 10, 2026

Alpha Cognition (ACOG) Slips Slightly as It Tests Key Support LevelsShort Term Trading Ideas - newsline.com

Jun 10, 2026

Jun 09, 2026

Major Investor Quietly Boosts Stake in Alpha Cognition Inc. With Fresh Buy - TipRanks

Jun 09, 2026

Alpha Cognition Reports Positive Top-Line Results from BEACON Real-World Study of ZUNVEYL® in Alzheimer’s Disease - BioSpace

Jun 09, 2026

ACOG Q1 2026 Earnings: EPS Beat on Narrower Loss; Still No RevenueEarnings Whisper Number - newsline.com

Jun 09, 2026

Alpha Cognition Reports Positive Top-Line Results Of Zunveyl® In Alzheimer’s Disease - TradingView

Jun 09, 2026

Jun 05, 2026